Latest News

 Filter by Provider

Sephience revenue hit $182 million as the company raised full-year guidance.

Revenue hit $511.5 million with enrollment climbing for 13th straight quarter.

Record backlog of $2.1 billion and raised earnings guidance signal strong momentum ahead.

Options revenue surged 19% as market share expanded and margins expanded dramatically.

Airo bookings doubled to $100M as AI platform becomes default in domain purchases.

Specialty pharmacy script volume surged 29% as home health integration accelerates.

Microsoft's fiscal Q1 2027 results beat forecasts, with Azure revenue up 48% and strong cash flow, prompting Cantor Fitzgerald and Piper Sandler to raise their MSFT price targets.

The foundry giant can still become a multibagger following a stellar run over the past five years.

Investing in bonds has been rough for several years, but current high yields present real opportunities.

Axon dominates law enforcement with 33.5% revenue growth and a sticky ecosystem, while Datadog scales cloud observability at 27.7% growth, but trades at double the valuation premium.

AstraZeneca stock gapped higher Friday as cancer drugs Enhertu and Tagrisso lent themselves to a solid third-quarter report.

R2 ramp drives 38% revenue growth as Rivian improves profitability outlook.

North American sales surged 9% amid seven quarters of inventory discipline.

Royalty revenue surged 51% on XOMA acquisition and Filspari momentum.

Record adjusted EPS of $0.99 surges 83% as aviation and marine segments outperform.

Record year-to-date originations and stable credit metrics drive platform growth.

Zero Q3 revenue, but three gate-all-around developers now engaged.

AI demand drives record bookings and 11% FFO growth for data center giant.

CEO Krishna credits technology shift for resilience amid mortgage market headwinds.

Margin expansion and emerging market strength offset European pricing headwinds.

AI adoption accelerates as platform targets 10% of global gaming market.

Core business grew 8-9% as profit margins expanded despite Amazon headwinds.

Prediction markets hit $200M annualized run rate within eight months of launch.

Hip and knee procedures slow as patient affordability pressures weigh on results.

Clinical sequencing demand drives margin expansion and full-year guidance hikes.

Environmental Solutions surged 21% as pricing gains drove upward guidance.

Data center revenue surged 61% sequentially as AI demand reshapes memory markets.

Record free cash flow and raised guidance signal strong AI momentum.

Adjusted EBITDAC surged 25% year-over-year to $1.25 billion.

There was a lot to like about the company's recent quarter, but liquidity remains a pressing issue.

Vanguard's ultra-low costs clash with State Street's superior recent returns. Sector tilts and volatility profiles diverge sharply between these two small-cap rivals.

Verizon is adding new subscribers at a strong clip, but Space Exploration Technologies is an overhang.

Record copper prices drove adjusted EBITDA to CAD 2.3 billion, up 97% year over year.

(BPT) - Key takeaways:

WEC raises guidance and unveils $47.5B five-year plan to power data center demand surge.

AUM surged 21% to $346 billion as capital formation accelerated across platforms.

Choice Properties REIT (TSX:CHP.UN) shares stand out as a compelling high-yield pick-up after an 11% drop.

Operating expenses are declining even as the company pivots to higher-value projects, testing whether cost discipline can sustain growth amid search headwinds.

Revenue surged 36.7% but profitability guidance fell as medical costs climbed.

Testing volumes surged 51% as NavDx integration drove revenue and margin gains.

Net income jumped 25% despite lower sales, backed by strong margins and $13.5B backlog.

Net sales grew 2% to $962.6 million as international strength offset U.S. wholesale delays.

Fuel headwinds offset revenue gains as net income rose 3% to $120 million.

Server CPU demand hit 15-year highs as AI infrastructure spending surged.

Niccol outlines tech modernization and store renovations for fiscal 2027 growth.

IKC outperformance helped offset tech investment drag in Q3.

Record $1.2B revenue driven by AI data center and communications strength.

Base business sales surged 16%, marking strongest growth in over a decade.

Net income surged 15.4% while deposit balances grew 14% year over year.

Revenue surged to $353.2 million as Attruby gains traction in rare disease markets.